HIV & STIs

Engaging men in HIV testing and care

UCSF Bixby Center
July 19, 2016
Compared to women, men have had lower levels of HIV testing and poor connections to care, especially in sub-Saharan Africa.

What can social science contribute to HIV/AIDS research?

UCSF Bixby Center
July 18, 2016

More than 30 years into HIV/AIDS in Africa, new treatment and prevention tools have brought us within reach of ending the epidemic.

Integrating HIV prevention into women’s health care

UCSF Bixby Center
July 8, 2016
Women’s health care providers are uniquely positioned to screen, counsel and offer PrEP. In a new commentary, UCSF Bixby researchers outline ways that obstetrician-gynecologists (ob-gyns) and other providers can integrate PrEP into standard care.

Increasing HIV testing among adolescents

UCSF Bixby Center
June 17, 2016

Among adolescents living with HIV, 80 percent live in sub-Saharan Africa. And young people ages 15-24 15–24 make up almost 40 percent of new HIV infections among adults.

Reversing the ban on sperm donations from MSM

UCSF Bixby Center
June 3, 2016
Currently, sperm donors must complete an HIV test, and may also be questioned about their sexual practices or required to undergo a physical exam to look for signs of anal intercourse. However, there is no evidence that these questions or the physical exam affect the chance of catching a false-negative HIV test.

Having a treatment buddy helps some HIV patients stay in care

UCSF Bixby Center
April 27, 2016

More than 7.6 million people living with HIV in African nations are now receiving drugs to keep the virus in check—known as antiretroviral therapy (ART).

Breaking ground in the Middle East: HIV risk among transgender people

UCSF Bixby Center
March 31, 2016
The UCSF Bixby Center is helping to better understand HIV among transgender women and their unique health needs. We are breaking ground in the Middle East, where HIV risk among transgender populations is mostly uncharted territory.

Vaginal ring helps protect women against HIV

UCSF Bixby Center
February 22, 2016

A vaginal ring containing an antiretroviral drug called dapivirine is safe and helped protect against HIV in a large-scale clinical trial involving more than 2,600 women in Zimbabwe, Malawi, Uganda

Vaginal ring helps protect women against HIV

Press Release
February 22, 2016
A vaginal ring containing an antiretroviral (ARV) drug called dapivirine that women inserted into their genital tract and used for a month at a time was safe and helped protect against HIV in a large-scale clinical trial involving more than 2,600 women in Zimbabwe, Malawi, Uganda and South Africa, researchers who conducted the trial, known as ASPIRE, reported today.

Respectfully reaching trans people at risk of HIV

UCSF Bixby Center
February 19, 2016
In an effort to reduce the number of people infected with HIV, many global and national strategies include a focus on specific populations at increased risk of infection. In a new study, UCSF Bixby Center researchers argue that the categories we use to identify those at elevated HIV risk are simultaneously vague and alienating for important groups.